Biogen Inc.

BIIB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$2,375,000$1,049,900$3,419,300$2,261,400
Short-Term Investments$0$0$1,473,500$1,541,100
Receivables$1,868,800$2,100,000$2,136,400$1,961,700
Inventory$2,460,500$2,527,400$1,344,400$1,351,500
Other Curr. Assets$752,500$1,182,000$1,417,600$740,800
Total Curr. Assets$7,456,800$6,859,300$9,791,200$7,856,500
Property Plant & Equip (Net)$3,537,700$3,729,700$3,702,500$3,791,800
Goodwill$6,478,900$6,219,200$5,749,000$5,761,100
Intangibles$9,691,200$8,363,000$1,850,100$2,221,300
Long-Term Investments$226,700$0$705,700$892,000
Tax Assets$324,200$928,600$1,226,400$1,415,100
Other NC Assets$333,800$745,000$1,529,200$1,939,500
Total NC Assets$20,592,500$19,985,500$14,762,900$16,020,800
Other Assets$0$0$0$0
Total Assets$28,049,300$26,844,800$24,554,100$23,877,300
Liabilities
Payables$424,200$403,300$491,500$589,200
Short-Term Debt$1,748,600$150,000$0$999,100
Tax Payable$548,300$257,400$259,900$174,700
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,807,700$2,623,600$2,521,400$2,535,200
Total Curr. Liab.$5,528,800$3,434,300$3,272,800$4,298,200
LT Debt$4,881,700$7,188,200$6,614,000$6,604,400
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$190,500$641,800$334,700$694,500
Other NC Liab.$732,300$781,100$944,200$1,320,500
Total NC Liab.$5,804,500$8,611,100$7,892,900$8,619,400
Other Liabilities$0$0$0$0
Cap. Leases$334,500$400,000$333,000$330,400
Total Liabilities$11,333,300$12,045,400$11,165,700$12,917,600
Equity
Pref Stock$0$0$0$0
Common Stock$100$100$100$100
Retained Earnings$19,259,800$17,627,600$16,466,500$13,911,700
AOCI-$136,200-$153,700-$164,900-$106,700
Other Equity-$2,407,700-$2,674,600-$2,903,800-$2,908,900
Total Equity$16,716,000$14,799,400$13,397,900$10,896,200
Supplemental Information
Minority Interest$0$0-$9,500$63,500
Total Liab. & Tot. Equity$28,049,300$26,844,800$24,554,100$23,877,300
Net Debt$4,255,300$6,288,300$3,194,700$5,342,100
Biogen Inc. (BIIB) Financial Statements & Key Stats | AlphaPilot